Payment overview · 2025
General Payments
$4,251.12
112 reported records · 22 companies
Healthcare provider profile · identity verified
Harsh Doshi, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease · PLAINFIELD, NJ · NPI 1912435884
Verified facts
What the public records show
CMS Open Payments records show Harsh Doshi, MD received $4,251.12 in general payments during 2025 across 112 reported records.
Medtronic, Inc. accounted for 23.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 53 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$1,012.16 | 23.8% | 29 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $600.71 | 14.1% | 12 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $473.82 | 11.2% | 16 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $435.47 | 10.2% | 9 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $310.98 | 7.3% | 9 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $275.45 | 6.5% | 2 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $229.88 | 5.4% | 4 | 2025 |
| CARDIVA MEDICAL, INC. | Unresolved — no canonical attribution shown | $205.39 | 4.8% | 8 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $97.29 | 2.3% | 3 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $94.62 | 2.2% | 4 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $79.71 | 1.9% | 2 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $68.36 | 1.6% | 3 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $61.05 | 1.4% | 1 | 2025 |
| Teleflex LLC | Unresolved — no canonical attribution shown | $49.90 | 1.2% | 2 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $42.50 | 1.0% | 1 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $41.25 | 1.0% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $38.65 | 0.9% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $36.67 | 0.9% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $28.73 | 0.7% | 1 | 2025 |
| Vital Connect, Inc | Unresolved — no canonical attribution shown | $23.28 | 0.6% | 1 | 2025 |
| Melinta Therapeutics, LLC | Unresolved — no canonical attribution shown | $23.24 | 0.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $22.01 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $4,251.12 | 112 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $473.82 | 16 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $304.29 | 7 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $278.13 | 4 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $275.45 | 2 | 2025 |
Source payment records
|
|||||
| FFRANGIO Normalized: ffrangio |
Device | Medtronic, Inc. | $203.13 | 3 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $200.54 | 6 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE 5F VCS Normalized: cardiva vascade 5f vcs |
Device | CARDIVA MEDICAL, INC. | $180.27 | 7 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $162.11 | 1 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $152.86 | 3 | 2025 |
Source payment records
|
|||||
| SYMPLICITY G3 Normalized: symplicity g3 |
Device | Medtronic, Inc. | $144.32 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $137.12 | 5 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $137.12 | 5 | 2025 |
Source payment records
|
|||||
| IV Other Normalized: iv other |
Device | Philips North America LLC | $121.76 | 3 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $97.29 | 3 | 2025 |
Source payment records
|
|||||
| Coronary Other Normalized: coronary other |
Device | Philips North America LLC | $88.09 | 3 | 2025 |
Source payment records
|
|||||
| Technical Education MRI Normalized: technical education mri |
Device | Philips North America LLC | $85.54 | 1 | 2025 |
Source payment records
|
|||||
| HT Bilevel Pro Core Normalized: ht bilevel pro core |
Device | Philips North America LLC | $84.34 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $79.71 | 2 | 2025 |
Source payment records
|
|||||
| Fighter Normalized: fighter |
Device | Boston Scientific Corporation | $75.54 | 2 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL VENOUS Normalized: mynx control venous |
Device | CORDIS US CORP. | $68.36 | 3 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $61.05 | 1 | 2025 |
Source payment records
|
|||||
| NANOCROSS ELITE Normalized: nanocross elite |
Device | Medtronic, Inc. | $58.21 | 2 | 2025 |
Source payment records
|
|||||
| CONCERTOTM Normalized: concertotm |
Device | Medtronic, Inc. | $58.19 | 4 | 2025 |
Source payment records
|
|||||
| Peripheral Vascular Undivided Normalized: peripheral vascular undivided |
Device | Philips North America LLC | $55.74 | 1 | 2025 |
Source payment records
|
|||||
| PROTEGE GPS Normalized: protege gps |
Device | Medtronic, Inc. | $47.51 | 1 | 2025 |
Source payment records
|
|||||
| Guidezilla Normalized: guidezilla |
Device | Boston Scientific Corporation | $43.04 | 1 | 2025 |
Source payment records
|
|||||
| CHOCOLATE PTA BALLOON CATHETER Normalized: chocolate pta balloon catheter |
Device | Medtronic, Inc. | $42.95 | 2 | 2025 |
Source payment records
|
|||||
| ALPHAVAC Normalized: alphavac |
Device | AngioDynamics, Inc. | $41.25 | 1 | 2025 |
Source payment records
|
|||||
| General - Atherectomy Normalized: general atherectomy |
Device | Boston Scientific Corporation | $39.73 | 1 | 2025 |
Source payment records
|
|||||
| Pounce LP Thrombectomy Normalized: pounce lp thrombectomy |
Device | Surmodics, Inc. | $38.65 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $38.65 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $38.65 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $38.65 | 1 | 2025 |
Source payment records
|
|||||
| Pounce XL Thrombectomy Normalized: pounce xl thrombectomy |
Device | Surmodics, Inc. | $38.65 | 1 | 2025 |
Source payment records
|
|||||
| PACIFIC XTREME Normalized: pacific xtreme |
Device | Medtronic, Inc. | $37.58 | 2 | 2025 |
Source payment records
|
|||||
| Wolverine Coronary Cutting Balloon Normalized: wolverine coronary cutting balloon |
Device | Boston Scientific Corporation | $37.16 | 1 | 2025 |
Source payment records
|
|||||
| Comet Normalized: comet |
Device | Boston Scientific Corporation | $37.15 | 1 | 2025 |
Source payment records
|
|||||
| FFR Link Normalized: ffr link |
Device | Boston Scientific Corporation | $36.90 | 1 | 2025 |
Source payment records
|
|||||
| TORCON NB Normalized: torcon nb |
Device | Cook Medical LLC | $33.22 | 1 | 2025 |
Source payment records
|
|||||
| ANGIO-SEAL Normalized: angio seal |
Device | Terumo Medical Corporation | $28.73 | 1 | 2025 |
Source payment records
|
|||||
| METACROSS OTW Normalized: metacross otw |
Device | Terumo Medical Corporation | $28.73 | 1 | 2025 |
Source payment records
|
|||||
| TURNPIKE Normalized: turnpike |
Device | Teleflex LLC | $28.39 | 1 | 2025 |
Source payment records
|
|||||
| PEEL-AWAY Normalized: peel away |
Device | Cook Medical LLC | $28.04 | 1 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE 6/7F VCS Normalized: cardiva vascade 6 7f vcs |
Device | CARDIVA MEDICAL, INC. | $25.12 | 1 | 2025 |
Source payment records
|
|||||
| IN.PACT ADMIRAL Normalized: in pact admiral |
Device | Medtronic, Inc. | $23.95 | 2 | 2025 |
Source payment records
|
|||||
| VITALPATCH RTM Normalized: vitalpatch rtm |
Device | Vital Connect, Inc | $23.28 | 1 | 2025 |
Source payment records
|
|||||
| Rezzayo Normalized: rezzayo |
Drug | Melinta Therapeutics, LLC | $23.24 | 1 | 2025 |
Source payment records
|
|||||
| AVVIGO Guidance System Normalized: avvigo guidance system |
Device | Boston Scientific Corporation | $23.15 | 1 | 2025 |
Source payment records
|
|||||
| VISI-PRO Normalized: visi pro |
Device | Medtronic, Inc. | $22.65 | 1 | 2025 |
Source payment records
|
|||||
| GUIDELINER Normalized: guideliner |
Device | Teleflex LLC | $21.51 | 1 | 2025 |
Source payment records
|
|||||
| ONYX FRONTIER Normalized: onyx frontier |
Device | Medtronic, Inc. | $20.27 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $18.31 | 1 | 2025 |
Source payment records
|
|||||
| COOK CELECT Normalized: cook celect |
Device | Cook Medical LLC | $6.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $4,251.12 · 112 records | Medtronic, Inc. | ABRE, ALPHAVAC, ANGIO-SEAL, AVVIGO Guidance System, CARDIVA VASCADE 5F VCS, CARDIVA VASCADE 6/7F VCS, CHOCOLATE PTA BALLOON CATHETER, CONCERTOTM, COOK CELECT, CT THROMBECTOMY SYSTEM KIT, Comet, Coronary Other, FFR Link, FFRANGIO, FLOWTRIEVER CATHETER, S, Fighter, GORE VIABAHN VBX Balloon Expandable Endo, GUIDELINER, General - Atherectomy, Guidezilla, HAWKONE, HT Bilevel Pro Core, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, IN.PACT ADMIRAL, IV Other, Indigo System, LUTONIX Drug Coated Balloon, METACROSS OTW, MYNX CONTROL VENOUS, NANOCROSS ELITE, ONYX FRONTIER, PACIFIC XTREME, PEEL-AWAY, PROTEGE GPS, Peripheral Vascular Undivided, Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce XL Thrombectomy, Rezzayo, RotarexS 6 F x 135 cm, SYMPHONY CATHETER, SYMPLICITY G3, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TORCON NB, TURNPIKE, Technical Education MRI, VISI-PRO, VITALPATCH RTM, WATCHMAN FLX, Wolverine Coronary Cutting Balloon | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error